Literature DB >> 15100265

IgG2a-mediated enhancement of antibody and T cell responses and its relation to inhibitory and activating Fc gamma receptors.

Andrew Getahun1, Jörgen Dahlström, Sara Wernersson, Birgitta Heyman.   

Abstract

A number of studies in experimental animal models point to an important role of Fc gamma Rs in autoimmunity and allergy. In this study, we investigate how the production of IgG, an early step in the chain of events leading to inflammation, is regulated by activating and inhibitory Fc gamma Rs. IgG Abs are known to feedback-enhance Ab responses to soluble Ags, and this effect requires activating Fc gamma Rs. To test proliferation of Th cells, mice were adoptively transferred with CD4(+) T cells expressing a transgenic OVA-specific TCR before immunization with IgG2a anti-2,4,6-trinitrophenyl (TNP) plus OVA-TNP or with OVA-TNP alone. IgG2a induced a significant increase in OVA-specific T cell numbers, which preceded the OVA-specific Ab response and was dependent on the Fc gamma chain. The role of the inhibitory Fc gamma RIIB in Ab responses was studied in mice lacking this receptor. Although IgG2a enhanced primary Ab responses, development of germinal centers, and immunological memory in wild-type mice, enhancement was markedly stronger in Fc gamma RIIB(-/-) mice. The presented data are compatible with the hypothesis that the mechanism behind IgG2a-mediated up-regulation of Ab responses involves increased Ag presentation to CD4(+) T cells by Fc gamma R(+) APCs. Our observations also illustrate the intricate immunoregulatory role of IgG Abs. On the one hand, they enhance Ab responses via activating Fc gamma Rs, and on the other hand, they set an upper limit for the same Ab response via Fc gamma RIIB.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100265     DOI: 10.4049/jimmunol.172.9.5269

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  28 in total

1.  Live attenuated Salmonella vaccines against Mycobacterium tuberculosis with antigen delivery via the type III secretion system.

Authors:  María Dolores Juárez-Rodríguez; Lourdes T Arteaga-Cortés; Rebin Kader; Roy Curtiss; Josephine E Clark-Curtiss
Journal:  Infect Immun       Date:  2011-12-05       Impact factor: 3.441

Review 2.  Antibody-mediated immunomodulation: a strategy to improve host responses against microbial antigens.

Authors:  L Jeannine Brady
Journal:  Infect Immun       Date:  2005-02       Impact factor: 3.441

Review 3.  IgG Fc Glycosylation in Human Immunity.

Authors:  Taia T Wang
Journal:  Curr Top Microbiol Immunol       Date:  2019       Impact factor: 4.291

4.  Improved tumor immunity using anti-tyrosinase related protein-1 monoclonal antibody combined with DNA vaccines in murine melanoma.

Authors:  Yvonne M Saenger; Yanyun Li; Karoline C Chiou; Brian Chan; Gabrielle Rizzuto; Stephanie L Terzulli; Taha Merghoub; Alan N Houghton; Jedd D Wolchok
Journal:  Cancer Res       Date:  2008-12-01       Impact factor: 12.701

5.  Recombinant soluble CD32 suppresses disease progression in experimental epidermolysis bullosa acquisita.

Authors:  Hiroaki Iwata; Elena Pipi; Nicole Möckel; Peter Sondermann; Artem Vorobyev; Nina van Beek; Detlef Zillikens; Ralf J Ludwig
Journal:  J Invest Dermatol       Date:  2014-10-20       Impact factor: 8.551

6.  Immunogenicity of protein therapeutics: The key causes, consequences and challenges.

Authors:  Matthew P Baker; Helen M Reynolds; Brooke Lumicisi; Christine J Bryson
Journal:  Self Nonself       Date:  2010-10

7.  Enhancement of anti-tumor CD8 immunity by IgG1-mediated targeting of Fc receptors.

Authors:  Scott N Furlan; Rajakumar Mandraju; Travis Brewer; Kole Roybal; Ty Dale Troutman; Wei Hu; Noah W Palm; Arun Unni; Chandrashekhar Pasare
Journal:  MAbs       Date:  2014 Jan-Feb       Impact factor: 5.857

Review 8.  Immunological responses to influenza vaccination: lessons for improving vaccine efficacy.

Authors:  Taia T Wang; Stylianos Bournazos; Jeffrey V Ravetch
Journal:  Curr Opin Immunol       Date:  2018-05-10       Impact factor: 7.486

9.  Autoantibody-boosted T-cell reactivation in the target organ triggers manifestation of autoimmune CNS disease.

Authors:  Anne-Christine Flach; Tanja Litke; Judith Strauss; Michael Haberl; César Cordero Gómez; Markus Reindl; Albert Saiz; Hans-Jörg Fehling; Jürgen Wienands; Francesca Odoardi; Fred Lühder; Alexander Flügel
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-08       Impact factor: 11.205

10.  Production of endocannabinoids by activated T cells and B cells modulates inflammation associated with delayed-type hypersensitivity.

Authors:  Jessica M Sido; Prakash S Nagarkatti; Mitzi Nagarkatti
Journal:  Eur J Immunol       Date:  2016-06       Impact factor: 5.532

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.